Published 13 February 2009, doi:10.1136/bmj.b592
Cite this as: BMJ 2009;338:b592

News

UK government rejects advice from drugs adviser to downgrade ecstasy

Zosia Kmietowicz

1 London

The first 150 words of the full text of this article appear below.

The Home Office has vetoed a recommendation from the independent drug advisory body to downgrade ecstasy from a class A to class B drug, saying it is not prepared to send a message to young people that it takes ecstasy less seriously.

Ecstasy is currently a class A drug along with heroin, crack cocaine, cocaine, and lysergide (LSD). Anyone found supplying drugs of this category can face a sentence of life in prison.

The Advisory Council on the Misuse of Drugs looked at more than 4000 papers for the first evidence based review into the effects of methylenedioxymethamphetamine (MDMA), commonly known as ecstasy, since the drug was classified in 1977. It said that ecstasy was no more dangerous than other amphetamines, which are class B drugs.

Alan Campbell, home office minister, said, "Ecstasy can and does kill unpredictably. The government has a duty to protect the public and firmly believes . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Classification of cannabis and ecstasy in the UK
Colin Blakemore
BMJ 2009 338: b731. [Extract] [Full Text]

Home secretary accused of bullying drugs adviser over comments about ecstasy
Zosia Kmietowicz
BMJ 2009 338: b612. [Extract] [Full Text]

This article has been cited by other articles:

  • Blakemore, C. (2009). Classification of cannabis and ecstasy in the UK. BMJ 338: b731-b731 [Full text]  

Rapid Responses:

Read all Rapid Responses

A different perspective.
Peter O'Loughlin, et al.
bmj.com, 22 Feb 2009 [Full text]
Access jobs at BMJ Careers
Whats new online at Student BMJ